BIOXYTRAN, INC. is a clinical stage biotechnology
Post# of 101
(Total Views: 187)
Posted On: 05/02/2023 3:06:51 PM
BIOXYTRAN, INC. is a clinical stage biotechnology business that is developing oral and injectable medications to treat COVID-19 and other viral diseases. The current OTC stock price represents a potential buying opportunity with a market value of $61.7 million.
(0)
(0)Bioxytran, Inc. (BIXT) Stock Research Links
Scroll down for more posts ▼